Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-995ml Total loading time: 0 Render date: 2024-03-28T20:24:49.376Z Has data issue: false hasContentIssue false

VIII.4 - Alzheimer’s Disease

from Part VIII - Major Human Diseases Past and Present

Published online by Cambridge University Press:  28 March 2008

Kenneth F. Kiple
Affiliation:
Bowling Green State University, Ohio
Get access

Summary

In 1906, Alois Alzheimer first described a neurological disorder of the brain associated with global deterioration of cognitive functioning and resulting in severe social impairment. Once thought rare, senile dementia of the Alzheimer’s type is the most commonly acquired progressive brain syndrome. Alzheimer’s disease begins with insidious intellectual and memory loss as the brain becomes shrunken from nerve cell loss and advances over 5 to 15 years to a chronic vegetative state. Progressive cognitive, psychological, and social dysfunction has a profound effect on family and friends. Alzheimer’s disease is associated with significant morbidity, and it may be the fourth leading cause of death in the United States (Katzman 1976). D. K. Kay and colleagues (1964) showed the average survival for demented men to be 2.6 years after the diagnosis of illness, whereas the survival period for nondemented men of the same age was 8.7 years. However, there is great variability in survival statistics from different studies.

Although Alzheimer’s disease is the leading cause of dementia, its etiology remains unknown, and treatment is supportive. The illness is a major problem among the elderly. Approximately 4 percent of the population over the age of 65 is affected, and by age 80, prevalence reaches 20 percent (Brodie 1982). As the elderly population of the United States increases, the number of persons with Alzheimer-type dementia will also increase. Alzheimer’s disease exists in the presenium, but it has been difficult to document a bimodal distribution with regard to age. Even though pathological changes in presenile and senile forms of the illness are similar, there is evidence that early- and late-onset Alzheimer-type dementia differ clinically (Seltzer and Sherwin 1983).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alafuzoff, I., et al. 1987. Histopathological criteria for progressive dementia disorders: Clinical pathological correlation and classification by multivariate data analysis. Ada Neuropathologica 74.Google ScholarPubMed
Albert, M. T., Feldman, R. G., and Willis, A. L.. 1974. The subcortical dementia of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry 37.CrossRefGoogle ScholarPubMed
Albert, M. T., et al. 1984. CT density numbers in patients with senile dementia of the Alzheimer type. Archives of Neurology 41.Google Scholar
Bartus, R. T., et al. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217.CrossRefGoogle ScholarPubMed
Beach, Thomas G. 1987. The history of Alzheimer’s disease: The debates. Journal of the History of Medicine and Allied Sciences 42.CrossRefGoogle ScholarPubMed
Blessed, G., Tomlinson, B. E., and Roth, M.. 1968. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 114.CrossRefGoogle ScholarPubMed
Brodie, J. A. 1982. An epidemiologist views senile dementia facts and fragments. American Journal of Epidemiology 115.Google Scholar
Christie, J. E., et al. 1981. Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. British Journal of Psychiatry 138.CrossRefGoogle ScholarPubMed
Cohen, E. L., and Wurtman, R. J.. 1976. Brain acetylcholine: Control by dietary choline. Science 191.CrossRefGoogle ScholarPubMed
Cook, R. H., et al. 1979. Studies in aging of the brain: IV. Familial Alzheimer disease: relation of transmissible dementia, aneuploidy, and microtubular defects. Neurology 29.CrossRefGoogle ScholarPubMed
Coyle, J. T., Price, D., and DeLong, M. R.. 1983. Alzheimer’s disease: A disorder of central cholinergic innervation. Science 219.CrossRefGoogle Scholar
Cummings, J. L., and Benson, D. F.. 1983. Dementia: A clinical approach. London.Google Scholar
Devanand, D. P., Sackeim, H. A., and Mayeux, R.. 1988. Psychosis, behavioral disturbance, and the use of neuroleptics in dementia. Comprehensive Psychiatry 29.CrossRefGoogle ScholarPubMed
Eisdorfer, C., and Cohen, D.. 1981. Management of the patient and family coping with dementing illness. Journal of Family Practice 12.Google ScholarPubMed
Folstein, M. F., Folstein, S. E., and McHugh, P. R.. 1975. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12.Google ScholarPubMed
Fox, T. H., Topel, J. L., and Huckman, M. S.. 1975. Use of computerized tomography in senile dementia. Journal of Neurology, Neurosurgery and Psychiatry 38.CrossRefGoogle ScholarPubMed
Gustafson, L., and Nilsson, L.. 1982. Differential diagnosis of presenile dementia on clinical grounds. Acta Psychiatrica Scandinavica 65.CrossRefGoogle ScholarPubMed
Harner, R. N. 1975. EEG evaluation of the patient with dementia. In Psychiatric aspects of neurologic disease, ed. Benson, D. F. and Blumer, D.. New York.Google Scholar
Haxby, J. V., et al. 1986. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer’s-type dementia. Archives of Neurology 43.CrossRefGoogle ScholarPubMed
Hersch, E. L. 1979. Development and application of the extended scale for dementia. Journal of the American Geriatrics Society 27.CrossRefGoogle ScholarPubMed
Heston, L. L., and Masri, A. R.. 1966. The genetics of Alzheimer’s disease: Associations with hematologic malignancy and Down’s syndrome. Archives of General Psychiatry 34.Google Scholar
Hughes, C. P., et al. 1982. A new clinical scale for the staging of dementia. British Journal of Psychiatry 140.CrossRefGoogle Scholar
Johnson, K. A., et al. 1987. Comparison of magnetic resonance and roentgen ray computed tomography in dementia. Archives of Neurology 44.CrossRefGoogle ScholarPubMed
Johnson, K. A., et al. 1988. Single photon emission computed tomography in Alzheimer’s disease: Abnormal iofetamine I123 uptake reflects dementia severity. Archives of Neurology 45.CrossRefGoogle Scholar
Katzman, R. 1976. The prevalence in malignancy of Alzheimer’s disease: A major killer (editorial). Archives of General Psychiatry 33.Google Scholar
Katzman, R. 1986. Alzheimer’s disease. New England Journal of Medicine 314.CrossRefGoogle ScholarPubMed
Kay, D. W. K., Beamish, P., and Roth, M.. 1964. Old age mental disorders in Newcastle-upon-Tyne. British Journal of Psychiatry 110.Google ScholarPubMed
Khachaturian, Z. S. 1985. Diagnosis of Alzheimer’s disease. Archives of Neurology 42.CrossRefGoogle ScholarPubMed
Kokmen, E. 1984. Dementia: Alzheimer type. Mayo Clinic Proceedings 59.CrossRefGoogle ScholarPubMed
Krai, B. A. 1962. Forgetfulness: Benign and malignant. Canadian Medical Association Journal. 86.Google Scholar
Markesbery, W. R., et al. 1981. Instrumental neutron activation analysis of brain aluminum in Alzheimer’s disease and aging. Annals of Neurology 10.Google ScholarPubMed
Marttila, R. J., and Rinne, U. K.. 1976. Dementia in Parkinson’s Disease. Acta Neurologica Scandinavica 54.CrossRefGoogle ScholarPubMed
Mayeux, R., Stern, Y., and Spanton, S.. 1985. Clinical heterogeneity in patients with dementia of the Alzheimer type: Evidence for subgroups. Neurology 35.CrossRefGoogle ScholarPubMed
McKhann, G., et al. 1984. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS–ADRDA ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34.CrossRefGoogle ScholarPubMed
Morris, J. C., et al. 1988. Consortium to establish a registry for Alzheimer’s disease. Psychopharmacology Bulletin 24.Google ScholarPubMed
Mundy-Castle, A. C., et al. 1953. The electroencephalogram in the senile psychosis. Electroencephalography and Clinical Neurophysiology 6.Google Scholar
Nuwer, M. R. 1988. Quantitative EEG: II. Frequency analysis and topographic mapping in clinical settings. Journal of Clinical Neurophysiology 5.Google ScholarPubMed
Rabins, Peter V. 1988. Science and medicine in the spotlight: Alzheimer’s disease as an example. Perspectives in Biology and Medicine 31.CrossRefGoogle ScholarPubMed
Reisberg, B., et al. 1982. The Global Deterioration Scale (GDS): An instrument for the assessment of primary degenerative dementia. American Journal of Psychiatry 139.Google Scholar
Reisberg, B., et al. 1983. The Brief Cognitive Rating Scale (BCRS): Findings in primary degenerative dementia. Psychopharmacology Bulletin 19.Google Scholar
Reisberg, Barry. 1983. Alzheimer’s disease. New York and London.Google Scholar
Reynolds, C. F., et al. 1983. Electroencephalographic sleep aging, and psychopathology: New data and state of art. Biological Psychiatry 18.Google Scholar
Salzman, C., Kochansky, G. E., and Shader, R. I.. 1972. Rating scales for geriatric psychopharmacology – a review. Psychopharmacology Bulletin 8.Google ScholarPubMed
Schenk, N. K., Reisberg, B., and Ferris, S. H.. 1982. An overview of current concepts of Alzheimer’s disease. American Journal of Psychiatry 139.Google Scholar
Seltzer, B., and Sherwin, I.. 1983. A comparison of clinical features in early and late-onset primary degenerative dementia: One entity or two? Archives of Neurology 40.CrossRefGoogle ScholarPubMed
Sharp, P., et al. 1986. Application of iodine-I123 labeled isopropylamphetamine imaging to the study of dementia. Journal of Nuclear Medicine 27.Google Scholar
Sojdel-Sulkhowska, E. M., and Marotta, C. A.. 1984. Alzheimer’s disease brain: Alterations in RNA levels and in a ribonuclease–inhibitor complex. Science 225.Google Scholar
Spor, J. E., and Gerner, R.. 1982. Does the dexamethasone suppression test distinguish dementia from depression? American Journal of Psychiatry 139.Google Scholar
St. George-Hyslop, P. H., et al. 1987. The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235.CrossRefGoogle ScholarPubMed
Stern, Y., Sano, M., and Mayeux, R.. 1988. Long-term administration of oral physostigmine in Alzheimer’s disease. Neurology 38.CrossRefGoogle ScholarPubMed
Summers, W. K., et al. 1986. Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer’s disease. New England Journal of Medicine 315.CrossRefGoogle Scholar
Terry, R. D., et al. 1981. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Annals of Neurology 10.CrossRefGoogle ScholarPubMed
Thal, L. J., et al. 1983. Oral physostigmine and lecithin improve memory in Alzheimer’s disease. Annals of Neurology 13.CrossRefGoogle Scholar
Tierney, M. C., et al. 1988. The NINCDS–ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: A clinicopathologic study of 57 cases. Neurology 38.CrossRefGoogle ScholarPubMed
Tomilson, D. E., Blessed, G., and Roth, M.. 1968. Observations on the brains of non-demented old people. Journal of the Neurological Sciences 7.Google Scholar
Tomilson, D. E., Blessed, G., and Roth, M.. 1970. Observations on the brains of demented old people. Journal of the Neurological Sciences 11.Google Scholar
Vannoy, John E., and Greene, James A.. 1989. Alzheimer’s disease: A brief history. Journal of the Tennessee Medical Association 82.Google ScholarPubMed
Visser, S. L., et al. 1976. Visual evoked response in senile and presenile dementia. Electroencephalography and Clinical Neurophysiology 40.CrossRefGoogle ScholarPubMed
Volicer, L., and Herz, L. R.. 1985. Pharmacologic management of Alzheimer-type dementia. American Family Physician 32.Google ScholarPubMed
Watts, H., Kennedy, P. G. E., and Thomas, M.. 1981. The significance of antineuronal antibodies in Alzheimer’s disease. Journal of Neuroimmunology 1.CrossRefGoogle Scholar
Wells, C. E. 1977. Dementia. Philadelphia.Google ScholarPubMed
Wells, C. E. 1979. Pseudodementia. American Journal of Psychiatry 136.Google ScholarPubMed
Wettstein, A., and Spiegel, R.. 1984. Clinical trials with the cholinergic drug RS86 in Alzheimer’s disease (AD) and senile dementia of the Alzheimer’s type (SDAT). Psychopharmacology 84.CrossRefGoogle Scholar
Wisniewski, H. M. 1978. Possible viral etiology of neurofibrillary changes and neuritic plagues. In Alzheimer’s disease: senile dementia and related disorders, ed. Katzman, R., Terry, R. D., and Beck, K. L.. New York.Google Scholar
Wisniewski, H. M. 1989. Alzheimer’s disease and related disorders. New York.Google Scholar
Wurtman, R. J., Hirsch, M, J., and Growdon, J.. 1977. Lecithin consumption raises serum free-choline levels. Lancet 2.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×